Skip to main content
. 2019 May 15;8(7):3544–3552. doi: 10.1002/cam4.2226

Figure 7.

Figure 7

KMT2A controls the colorectal cancer hepatic metastasis in vivo. A and B, The injection of HCT116 cells with inhibited KMT2A into spleen led to decreased information of liver metastasis. C, Hematoxylin and eosin staining (10×) showed that inhibited KMT2A led to decreased information of liver metastasis. D, A schematic diagram of model displaying the implication of KMT2A promoting cathepsin Z (CTSZ) transcriptional activation. ***P < 0.001